TNFRSF8 and neoplasm: Third, BV may exert immunomodulatory effects within the tumor microenvironment (TME), including the depletion of CD30-expressing regulatory T cells (Tregs) and tumor-associated macrophages (TAMs) [41,42], which could restore effector T-cell activity and enhance antitumor immunity.